Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Scleroderma Research Foundation, Inc.

Clinical trials sponsored by Scleroderma Research Foundation, Inc., explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

New hope for scleroderma lung disease: major trial underway Results expected Nov 2026 (estimated)

Browse trials soon ready across all sponsors →

Trials to join now! 1

New hope for scleroderma lung disease: major trial underway

Disease control Recruiting now

This study tests whether new investigational drugs can improve lung function in people with scleroderma-related lung scarring. About 400 adults with this condition will receive either the study drug or a placebo for 52 weeks. The main goal is to see if the drug helps preserve or …

Phase 2 • Sponsor: Scleroderma Research Foundation, Inc. • Aim: Disease control

Last updated Aug 20, 2026 00:00 UTC